Interleukin-1β in innate inflammation, autophagy and immunity

Seminars in Immunology

Volumn 25, Issue 6, 2013, Pages 416-424

  Joosten, Leo A B ^a   Netea, Mihai G ^a   Dinarello, Charles A ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Caspase 1 independent; Innate inflammation; Interleukin 1

Indexed keywords

CD28 ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE;

ARTHRITIS; ARTHROPATHY; AUTOPHAGY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GAIN OF FUNCTION MUTATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MEMORY T LYMPHOCYTE; METASTASIS; NONHUMAN; REVIEW;

AUTOPHAGY; CASPASE-1-INDEPENDENT; INNATE INFLAMMATION; INTERLEUKIN-1Β;

ANIMALS; ANTIGENS, CD28; ARTHRITIS, RHEUMATOID; AUTOPHAGY; CARRIER PROTEINS; CASPASE 1; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; NEOPLASM METASTASIS; NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTORS, PURINERGIC P2X7; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTOR 4;

EID: 84892852797     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.10.018     Document Type: Review

References (111)

1. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., McMahan C.J., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988, 241:585-589.
2. Gay N.J., Keith F.J. Drosophila Toll and IL-1 receptor. Nature 1991, 351:355-356.
3. Heguy A., Baldari C.T., Macchia G., Telford J.L., Melli M. Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction. J Biol Chem 1992, 267:2605-2609.
4. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
5. van der Meer J.W.M., Barza M., Wolff S.M., Dinarello C.A. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci U S A 1988, 85:1620-1623.
6. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008, 226:10-18.
7. Rosenwasser L.J., Dinarello C.A., Rosenthal A.S. Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen. J Exp Med 1979, 150:709-714.
8. Dinarello C.A. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol 2011, 41:1203-1217.
9. Okamoto M., Liu W., Luo Y., Tanaka A., Cai X., Norris D.A., et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 2009, 285:6477-6488.
10. Croker B.A., Lewis R.S., Babon J.J., Mintern J.D., Jenne D.E., Metcalf D., et al. Neutrophils require SHP1 to regulate IL-1beta production and prevent inflammatory skin disease. J Immunol 2011, 186:1131-1139.
11. Unlu S., Kumar A., Waterman W.R., Tsukada J., Wang K.Z., Galson D.L., et al. Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol Immunol 2007, 44:3364-3379.
12. Kaspar R.L., Gehrke L. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1b mRNA show unequal IL-1b protein accumulation but similar polyribosome profiles. J Immunol 1994, 153:277-286.
13. Bufler P., Gamboni-Robertson F., Azam T., Kim S.H., Dinarello C.A. Interleukin-1 homologues IL-1F7b IL-18 contain functional mRNA. instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004, 381:503-510.
14. Schindler R., Clark B.D., Dinarello C.A. Dissociation between interleukin-1b mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 1990, 265:10232-10237.
15. Dinarello C.A., Ikejima T., Warner S.J., Orencole S.F., Lonnemann G., Cannon J.G., et al. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987, 139:1902-1910.
16. Goldbach-Mansky R., Dailey N.J., Canna S.W., Gelabert A., Jones J., Rubin B.I., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. New Engl J Med 2006, 355:581-592.
17. Greten F.R., Arkan M.C., Bollrath J., Hsu L.C., Goode J., Miething C., et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007, 130:918-931.
18. Boni-Schnetzler M., Thorne J., Parnaud G., Marselli L., Ehses J.A., Kerr-Conte J., et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 2008, 93:4065-4074.
19. Gattorno M., Tassi S., Carta S., Delfino L., Ferlito F., Pelagatti M.A., et al. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 2007, 56:3138-3148.
20. Wewers M.D., Dare H.A., Winnard A.V., Parker J.M., Miller D.K. IL-1b-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1b release limitation is ICE independent. J Immunol 1997, 159:5964-5972.
21. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
22. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta processing inflammasome with increased activity in Muckle-Wells auto-inflammatory disorder. Immunity 2004, 20:319-325.
23. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301-305.
24. Drenth J.P., van der Meer J.W., Kushner I. Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. J Immunol 1996, 157:400-404.
25. Hoffman H.M., Wanderer A.A. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep 2011, 10:229-235.
26. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A., Opitz B., van der Meer J.H., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
27. Andrei C., Dazzi C., Lotti L., Torrisi M.R., Chimini G., Rubartelli A. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 1999, 10:1463-1475.
28. Andrei C., Margiocco P., Poggi A., Lotti L.V., Torrisi M.R., Rubartelli A. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. Proc Natl Acad Sci U S A 2004, 101:9745-9750.
29. Gardella S., Andrei C., Costigliolo S., Olcese L., Zocchi M.R., Rubartelli A. Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells. Blood 2000, 95:3809-3815.
30. Perregaux D.G., McNiff P., Laliberte R., Conklyn M., Gabel C.A. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000, 165:4615-4623.
31. Elssner A., Duncan M., Gavrilin M., Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004, 172:4987-4994.
32. Qu Y., Franchi L., Nunez G., Dubyak G.R. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 2007, 179:1913-1925.
33. Brough D., Rothwell N.J. Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci 2007, 120:772-781.
34. Suzuki T., Franchi L., Toma C., Ashida H., Ogawa M., Yoshikawa Y., et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 2007, 3:e111.
35. Kahlenberg J.M., Lundberg K.C., Kertesy S.B., Qu Y., Dubyak G.R. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol 2005, 175:7611-7622.
36. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H.I., Spinas G.A., et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002, 110:851-860.
37. Pascual V., Allantaz F., Arce E., Punaro M., Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005, 201:1479-1486.
38. Al-Shukaili A., Al-Kaabi J., Hassan B. A comparative study of interleukin-1beta production and p2×7 expression after ATP stimulation by peripheral blood mononuclear cells isolated from rheumatoid arthritis patients and normal healthy controls. Inflammation 2008, 31:84-90.
39. Sluyter R., Shemon A.N., Wiley J.S. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol 2004, 172:3399-3405.
40. Sluyter R., Dalitz J.G., Wiley J.S. P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 2004, 5:588-591.
41. Lee K.H., Park S.S., Kim I., Kim J.H., Ra E.K., Yoon S.S., et al. P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Haematologica 2007, 92:651-657.
42. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
43. Hewinson J., Moore S.F., Glover C., Watts A.G., MacKenzie A.B. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes. J Immunol 2008, 180:8410-8420.
44. Pelegrin P., Surprenant A. Pannexin-1 mediates large pore formation interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 2006, 25:5071-5082.
45. Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.
46. Derks R., Beaman K. Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1 beta secretion in human macrophages. Hum Immunol 2004, 65:676-682.
47. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140.
48. Meissner F., Molawi K., Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 2008, 9:866-872.
49. van de Veerdonk F.L., Smeekens S.P., Joosten L.A., Kullberg B.J., Dinarello C.A., van der Meer J.W., et al. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A 2010, 107:3030-3033.
50. Meissner F., Seger R.A., Moshous D., Fischer A., Reichenbach J., Zychlinsky A. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 2010, 116:1570-1573.
51. van de Veerdonk F.L., Netea M.G., Dinarello C.A., van der Meer J.W. Anakinra for the inflammatory complications of chronic granulomatous disease. Neth J Med 2011, 69:95.
52. Fantuzzi G., Ku G., Harding M.W., Livingston D.L., Sipe J.D., Kuida K., et al. Response to local inflammation of IL-1b converting enzyme-deficient mice. J Immunol 1997, 158:1818-1824.
53. Zheng H., Fletcher D., Kozak W., Jiang M., Hofmann K., Conn C.C., et al. Resistance to fever induction and impaired acute-phase response in interleukin-1b deficient mice. Immunity 1995, 3:9-19.
54. Fantuzzi G., Sacco S., Ghezzi P., Dinarello C.A. Physiological and cytokine responses in interleukin-1b-deficient mice after zymosan-induced inflammation. Am J Physiol 1997, 273:R400-R406.
55. Fantuzzi G., Zheng H., Faggioni R., Benigni F., Ghezzi P., Sipe J.D., et al. Effect of endotoxin in IL-1b-deficient mice. J Immunol 1996, 157:291-296.
56. Faggioni R., Fantuzzi G., Fuller J., Dinarello C.A., Feingold K.R., Grunfeld C. IL-1b mediates leptin induction during inflammation. Am J Physiol 1998, 274:R204-R208.
57. Krelin Y., Voronov E., Dotan S., Elkabets M., Reich E., Fogel M., et al. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 2007, 67:1062-1071.
58. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442.
59. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. New Engl J Med 2011, 365:2205-2219.
60. Schett G., Elewaut D., McInnes I.B., Dayer J.M., Neurath M.F. How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat Med 2013, 19:822-824.
61. Joosten L.A., Helsen M.M., Saxne T., van De Loo F.A., Heinegard D., van Den Berg W.B. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 1999, 163:5049-5055.
62. Joosten L.A., Helsen M.M., van de Loo F.A., van den Berg W.B. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum 1996, 39:797-809.
63. Zwerina J., Redlich K., Polzer K., Joosten L., Kronke G., Distler J., et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A 2007, 104:11742-11747.
64. van de Loo F.A., Joosten L.A., van Lent P.L., Arntz O.J., van den Berg W.B. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995, 38:164-172.
65. van de Loo F.A., Arntz O.J., Otterness I.G., van den Berg W.B. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 1992, 19:348-356.
66. van de Loo A.A., van Beuningen H.M., van Lent P.L., van den Berg W.B. Direct effect of murine rIL-1 on cartilage metabolism in vivo. Agents Actions 1989, 26:153-155.
67. Santambrogio L., Hochwald G.M., Saxena B., Leu C.H., Martz J.E., Carlino J.A., et al. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J Immunol 1993, 151:1116-1127.
68. Ku G., Ford B.S., Raybuck S.A., Harding M.W., Randle J.C.R. Selective interleukin-1 converting enzyme (ICE/Caspase-1) inhibition with pralnacasan (HMR 3480/VX-740) reduces inflammation and joint destruction in murine type II collagen-induced arthritis (CIA). Arthritis Rheum 2001, 44(suppl. 9):1134.
69. Saijo S., Asano M., Horai R., Yamamoto H., Iwakura Y. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum 2002, 46:533-544.
70. Mori L., Iselin S., De Libero G., Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol 1996, 157:3178-3182.
71. Campbell I.K., O'Donnell K., Lawlor K.E., Wicks I.P. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 2001, 107:1519-1527.
72. Joosten L.A., Abdollahi-Roodsaz S., Heuvelmans-Jacobs M., Helsen M.M., van den Bersselaar L.A., Oppers-Walgreen B., et al. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17. Arthritis Rheum 2008, 58:98-108.
73. So A., De Smedt T., Revaz S., Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28.
74. So A., De Meulemeester M., Pikhlak A., Yucel A.E., Richard D., Murphy V., et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. Arthritis Rheum 2010, 62:3064-3076.
75. Joosten L.A., Netea M.G., Mylona E., Koenders M.I., Malireddi R.K., Oosting M., et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010, 62:3237-3248.
76. Joosten L.A., Netea M.G., Fantuzzi G., Koenders M.I., Helsen M.M., Sparrer H., et al. Inflammatory arthritis in caspase 1 gene-deficient mice: Contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 2009, 60:3651-3662.
77. Guma M., Ronacher L., Liu-Bryan R., Takai S., Karin M., Corr M. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 2009, 60:3642-3650.
78. Coeshott C., Ohnemus C., Pilyavskaya A., Ross S., Wieczorek M., Kroona H., et al. Converting enzyme-independent release of TNFa and IL-1b from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase-3. Proc Natl Acad Sci U S A 1999, 96:6261-6266.
79. Sugawara S., Uehara A., Nochi T., Yamaguchi T., Ueda H., Sugiyama A., et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 2001, 167:6568-6575.
80. Schlesinger N., Mysler E., Lin H.Y., De Meulemeester M., Rovensky J., Arulmani U., et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheum Dis 2011, 70:1264-1271.
81. Numanami H., Koyama S., Sato E., Haniuda M., Nelson D.K., Hoyt J.C., et al. Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro. Am J Physiol Lung Cell Mol Physiol 2003, 284:L882-L890.
82. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007, 8:931-937.
83. Schmid D., Munz C. Innate and adaptive immunity through autophagy. Immunity 2007, 27:11-21.
84. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268.
85. Harris J., Hartman M., Roche C., Zeng S.G., O'Shea A., Sharp F.A., et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 2011, 286:9587-9597.
86. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011, 12:222-230.
87. Tschopp J., Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol 2010, 10:210-215.
88. Crisan T.O., Plantinga T.S., van de Veerdonk F.L., Farcas M.F., Stoffels M., Kullberg B.J., et al. Inflammasome-independent modulation of cytokine response by autophagy in human cells. PLoS One 1866, 6:e6.
89. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39:207-211.
90. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
91. Henckaerts L., Cleynen I., Brinar M., John J.M., Van Steen K., Rutgeerts P., et al. Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease. Inflamm Bowel Dis 2011, 17:1392-1397.
92. Lapaquette P., Glasser A.L., Huett A., Xavier R.J., Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010, 12:99-113.
93. Plantinga T.S., Crisan T.O., Oosting M., van de Veerdonk F.L., de Jong D.J., Philpott D.J., et al. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 2011, 60:1229-1235.
94. Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010, 16:90-97.
95. Homer C.R., Richmond A.L., Rebert N.A., Achkar J.P., McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 1641, 139:1630-1641. 1641, e1631-e1632.
96. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhaes J.G., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010, 11:55-62.
97. Kuballa P., Huett A., Rioux J.D., Daly M.J., Xavier R.J. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One 2008, 3:e3391.
98. Oh J.E., Lee H.K. Modulation of pathogen recognition by autophagy. Front Immunol 2012, 3:44.
99. Ponpuak M., Davis A.S., Roberts E.A., Delgado M.A., Dinkins C., Zhao Z.J., et al. Delivery of Cytosolic Components by Autophagic Adaptor Protein p62 Endows Autophagosomes with Unique Antimicrobial Properties. Immunity 2010, 32:329-341.
100. Kundu M., Thompson C.B., Autophagy: Basic principles and relevance to disease. Annu Rev Pathol-Mech 2008, 3:427-455.
101. Marquez A., Nunez C., Martinez A., Mendoza J.L., Taxonera C., Fernandez-Arquero M., et al. Role of ATG16L1 Thr300Ala Polymorphism in Inflammatory Bowel Disease: A Study in the Spanish Population and a Meta-analysis. Inflamm Bowel Dis 2009, 15:1697-1704.
102. Zhang H.F., Qiu L.X., Chen Y., Zhu W.L., Mao C., Zhu L.G., et al. ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet 2009, 125:627-631.
103. Buffen K., Oosting M., Mennens S., Anand P.K., Plantinga T.S., Sturm P., et al. Autophagy modulates Borrelia burgdorferi-induced production of interleukin-1β (IL-1β). J Biol Chem 2013, 288:8658-8666.
104. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Ann Rev Immunol 2001, 19:423-474.
105. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
106. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
107. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
108. Chizzolini C., Chicheportiche R., Alvarez M., de Rham C., Roux-Lombard P., Ferrari-Lacraz S., et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008, 112:3696-3703.
109. Henley D.V., Bellone C.J., Williams D.A., Ruh T.S., Ruh M.F. Aryl hydrocarbon receptor-mediated posttranscriptional regulation of IL-1beta. Arch Biochem Biophys 2004, 422:42-51.
110. Moreira A.P., Cavassani K.A., Ismailoglu U.B., Hullinger R., Dunleavy M.P., Knight D.A., et al. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J Clin Invest 2011, 121:4420-4432.
111. Hughes T., Becknell B., Freud A.G., McClory S., Briercheck E., Yu J., et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010, 32:803-814.